News Center

Jian Kang Yuan and livzon Group were awarded the "Special Contribution Award" and the "Chinese Red Cross Love Medal" by the Chinese Red Cross Society.


Release time:

2024-05-09

Recently, the Red Cross Society of China issued a notice regarding the "Awarding of Medals to Donors Who Have Made Outstanding Contributions to the Cause of the Red Cross in China in 2023", with Lizhu Group and its parent company, Health Yuan Group, being awarded."Special Contribution Award" and "Chinese Red Cross Love Medal".

 

 
On the evening of December 18, 2023, a 6.2 magnitude earthquake struck Jishishan County, Linxia Prefecture, Gansu Province. When one side is in trouble, support comes from all sides. Health Yuan and Lizhu Group donated a total of 20 million yuan in rescue funds and medical supplies to the disaster area through the Zhuhai Red Cross Society, including 10 million yuan in cash and 10 million yuan worth of medicines, for emergency rescue efforts in the affected areas, living arrangements for the affected population, support for rescue teams, and post-disaster reconstruction.
 

Since its establishment, Lizhu Group has actively fulfilled its social responsibilities and adhered to the commitments of a pharmaceutical company. Since 2008, in collaboration with its parent company Health Yuan Group, leveraging its industrial advantages, it has launched the "Universal Chronic Disease Prevention and Treatment Public Welfare Project" and has continuously engaged in drug donation activities. To date, the project has signed 26 agreements, covering 8 provinces and 4 autonomous regions across the country, assisting nearly 20,000 low-income chronic disease patients. In recent years, the total investment in public welfare and charity, including "Universal Chronic Disease Prevention and Treatment", industrial assistance, educational funding, and earthquake relief, has exceeded 100 million yuan, fully reflecting the responsibilities and commitments of private enterprises in the new era. In the future, Lizhu Group will continue to uphold the original intention of pharmaceutical responsibilities, actively participate in public welfare and charity, and make significant contributions to society.

Related Information